Stem Cell Network

SCN is a Canadian not-for-profit supporting stem cell and regenerative medicine research, training, and knowledge mobilization.

[Stem Cell Network @StemCellNetwork]

IMPORTANT NEWS: SCN is now on @bluesky!

As of Friday, January 10, 2025, we will no longer be active on X. Stay connected with us on Bluesky for the latest insights, research, and developments in #StemCells and #RegenerativeMedicine.

Follow us here. ➡️ https://t.co/YNc2JGMsw8

[Stem Cell Network @StemCellNetwork]

(2/2) Continuez de nous suivre sur Bluesky pour rester au fait des éclairages, des recherches et des développements les plus récents sur les #CellulesSouches et la #MédecineRégénératrice.

Notre adresse. ➡️ https://t.co/YNc2JGMsw8

[Stem Cell Network @StemCellNetwork]

(1/2) NOUVELLE IMPORTANTE : Le RCS est passé à @bluesky! À compter du vendredi 10 janvier 2025, nous ne serons plus présents sur X.

Notre adresse. ➡️ https://t.co/YNc2JGMsw8

[Medicine by Design @MbD_CCRM]

Application period extended to Jan. 20! Apply to participate in this program that gives PhD students & post-docs a foundation in the commercialization & business aspects of #regenmed. Hosted by #MedicinebyDesign with partners CCRM, @StemCellNetwork & @rotmanschool.

[Stem Cell Network @StemCellNetwork]

(2/2) This workshop, hosted by SCN and @BioCanRx, brings together expert facilitators like Rebecca L Davies and Gayle Piat to help researchers strengthen their #DataManagement practices and promote #ResearchIntegrity. A big thank you to everyone who joined us today!

[Stem Cell Network @StemCellNetwork]

(1/2) Best Practices for Collecting, Documenting, and Managing Research Data and Records is officially underway! SCN's President & CEO, @cate_murray1, helped kick off the workshop alongside @BioCanRx's Acting Director, Scientific Affairs & Training Program, Julie Jonkhans.

[Stem Cell Network @StemCellNetwork]

Congrats to Aspect Biosystems on closing their US$115M Series B round! 👏 This milestone will accelerate bioprinted tissue therapeutics, advancing treatments for serious diseases.

Shoutout to @_tamerm, Founder & CEO of @aspectbiosys and Board Member of SCN, and the entire team!

[Aspect Biosystems @aspectbiosys]

We’re thrilled to announce that we have closed a US$115 million Series B financing round to advance the development of bioprinted tissue therapeutics.

Learn more: https://t.co/wipHS5z760

[Stem Cell Network @StemCellNetwork]

Planning to apply for the J. Andrew McKee Fellowship? The notice of intent is due on Jan 30, 2025!

Supported by SCN and @BT1D_CA (formerly JDRF), this is your chance to join @UBC’s Breakthrough T1D Centre of Excellence. Submit your application here. ➡️ https://t.co/dDWHluBbrX

[Stem Cell Network @StemCellNetwork]

📢 Calling all trainees / HQPs!

Applications for SCN’s International Travel Awards are open. Don’t miss your chance to present your research internationally between January 1 - March 31, 2025.

Learn more and apply now. ➡️ https://t.co/lMH1UUIMmr

[Stem Cell Network @StemCellNetwork]

Ready to advance Type 1 Diabetes research?

The Andrew McKee Fellowship at @UBC's @BreakthroughT1D Centre of Excellence is open for applications! All post-docs are invited to apply for this opportunity. 🌐

➡️ https://t.co/dDWHluBJhv

[Stem Cell Network @StemCellNetwork]

#ICYMI: In partnership with @MitacsCanada, SCN’s internship program empowers the next generation of #RegenMed leaders! Five interns are gaining hands-on experience with biotech companies, driving forward innovative therapies. Read our latest Insights Blog! https://t.co/2IsFkiYE2P

[Stem Cell Network @StemCellNetwork]

Le RCS cell-èbre cette période de réjouissances en vous souhaitant de merveilleuses fêtes✨

Nous vous souhaitons santé, bonheur et des réussites des plus souche-taculaires au cours de la nouvelle année!

[Stem Cell Network @StemCellNetwork]

We’d like to cell-abrate this joyful season by wishing you a wonderful holiday on behalf of SCN! ✨

Wishing you health, happiness, and stem-tacular success in the year ahead!

[Stem Cell Network @StemCellNetwork]

Interested in staying updated on the latest #StemCell research and #RegenMed news? CellLines has got you covered. 📩

Find articles of interest, new training opportunities, upcoming research funding opportunities, updates from across the Network, and more! https://t.co/WCRLA9kAvi

[Stem Cell Network @StemCellNetwork]

⏳ Time's running out to apply for #SummerByDesign 2025!

PhD students & postdocs in #RegenMed will:
🔬 Explore pathways from lab to impact
🌟 Learn commercialization & career options
🤝 Network with industry leaders

📅 June 2–11, 2025
📍@UofT
🔗 https://t.co/Z5ky614WUc

[Stem Cell Network @StemCellNetwork]

Have you applied for SCN’s International Travel Awards? ✈️

This award supports trainees and HQPs to attend conferences on #StemCells and #RegenerativeMedicine worldwide. Apply now for travel between January 1 - March 31, 2025. ➡️ https://t.co/lMH1UUJkbZ

[Medicine by Design @MbD_CCRM]

The #SummerbyDesign deadline is approaching! The international program gives PhD students & post-docs the skills to commercialize #regenmed. Hosted by #MedicinebyDesign, @CCRM_ca, @StemCellNetwork, @rotmanschool. Learn more & apply: https://t.co/13Au737ZoZ

[Stem Cell Network @StemCellNetwork]

📢 SCN and @MitacsCanada are seeking #biotech companies to host graduate students and postdocs for the 2025-2026 internship program. If you're a Canadian company with a #StemCell-focused project, apply now to host an intern! 🧬

🔗 https://t.co/wCi6jurqlO

[Stem Cell Network @StemCellNetwork]

Pleased to partner with weCANreg to deliver the "Regulatory Literacy Course," equipping future biotech leaders with the tools to navigate regulatory pathways.

By connecting trainees with experts, we’re strengthening Canada’s regulatory ecosystem to support life-changing tech.🔬

[Cate Murray @cate_murray1]

Pleased to attend the Cancer Caucus & Parliamentary Health Research Caucus event yesterday, hosted by @ResearchCda and @cancersociety.

What a powerful discussion on disruptive innovation in #CancerResearch, #ClinicalTrials, and their impact on patient outcomes.